STROKE By Dr. Bikha Ram Devrajani FCPS, FACP, FRCP Professor Medicine Liaquat University of Medical & Health Sciences, Jamshoro BIKHA Definition of Stroke Acute focal neurological deficit resulting from cerebrovascular disease and lasting more than 24-hours (or causing earlier death) BIKHA Definition of Stroke Stroke is not a diagnosis but a clinical syndrome with numerous causes The main types of stroke and their relative occurrence are: Cerebral infarction (85%) Intracerebral haemorrhage (10%) Subarachnoid haemorrhage (5%) BIKHA Transient Ischaemic Attack (TIA) Also defined as an acute focal neurological deficit resulting from cerebrovascular disease, but the symptoms and signs resolve within 24-hours Most patients recover within 30-min No fundamental difference between TIA and stroke except for the duration of the symptoms BIKHA Epidemiology of Stroke Stroke is the third leading cause of death in the United States and a leading cause of serious, long-term disability. In the United States there is one stroke patient in every 45 seconds. BIKHA Haemorrhagic 15% Ischaemic 85% BIKHA Thromboembolism Heart 25% Large Vessels and others 50% Small Vessel Disease 25% BIKHA BIKHA Pathophysiology Clinical Classification of Focal Stroke. Transient if the deficit recover within 24 h. Completed if the focal deficit is persistent. Evolving if focal deficit continues to worsen after about 6 h from onset. BIKHA Pathophysiology Cerebral Infarction Infarction is a process which takes some hours to complete. BIKHA Pathophysiology Cerebral Infarction a. Occlusion of a cerebral artery, the opening of anastomatic channels from other arterial territories may restore perfusion. b. Reduction in perfusion pressure leads to homeostatic changes to maintain oxygenation of brain vasodilation of cerebral artery. BIKHA Cerebral Infarction Pathophysiology c. If homeostatic process fails ischaemia begins - ultimately leads to infarction. i. When the blood-flow falls below threshold for maintenance of electrical activity neurological deficit appears – but neurons are still viable. At this stage if blood-flow restores then recovery will be definite (TIA). ii. If flow further falls, then cell death process starts. BIKHA Pathophysiology BIKHA Pathophysiology Cerebral Infarction Final result of occlusion of a cerebral blood vessel depends upon: i. Competence of the circulatory homeostatic mechanism. ii. Severity of reduction of blood-flow. iii. Duration of reduction of blood-flow. BIKHA Pathophysiology BIKHA Pathophysiology Cerebral Infarction If ischaemic damage is affecting the endothelium of vessel then there is chance of haemorrhage in the infarction by blood’s thrombolytic mechanism. BIKHA Pathophysiology Cerebral Infarction Radiologically infarct can be seen as a lesion which is composed of: • Ischaemic. • Swollen but recoverable (pnemubra). • Finally infarcted area will be replaced fluid filled cavity (liquification necrosis). BIKHA Ischaemia Energy Failure Depolarization Glutamate Release Na+/Ca++ Influx Cellular Swelling Free Radical Generation Mitochondrial Injury Necrotic Cell Death Enzyme Activity BIKHA BIKHA BIKHA BIKHA Pathophysiology Intracerebral Haemorrhage Cessation of functions of affected parts. As neurons are structurally distrupted and white matter fibre tract split apart. Rim of cerebral oedema around haemorrhage. BIKHA Pathophysiology Intracerebral Haemorrhage If big haemorrhage the shifting of midline and transtentorial causing rapid death. If survives then haemosidrin lined slit in brain parenchyma. BIKHA CT Scan of Intracerebral Haemorrhage BIKHA Causes of Cerebral Infarction (75-80% of all strokes) Large artery atherothromboembolism =50% • Extracranial (aorta, carotid, vertebral arteries) = 40-45% • Intracranial (ICA, MCA, ACA, vertebral, basilar, PCA) = 5-10% Small artery diseases (microatheroma/lipohyalinosis) = 20-25% BIKHA BIKHA Causes of Cerebral Infarction (75-80% of all strokes) Large artery atherothromboembolism =50% • Extracranial (aorta, carotid, vertebral arteries) = 40-45% • Intracranial (ICA, MCA, ACA, vertebral, basilar, PCA) = 5-10% Small artery diseases (microatheroma/lipohyalinosis) = 20-25% BIKHA Causes of Cerebral Infarction (75-80% of all strokes) Contd: Embolism from the heart = 20% Non-atheromatous arterial disease (e.g. dissection, arteritis) = 5% Blood disease (thrombophilia) <5% BIKHA Cardiac Sources of Embolism (in anatomical sequence) BIKHA Cardiac Sources of Embolism (in anatomical sequence) Right to left shunt (paradoxical emboli from the venous system) via: Patent foramen ovale Atrial septal defect Ventricular septal defect Pulmonary arteriovenous malformation BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd. Left Atrium Thrombus: • atrial fibrillation* • sinoatrial disease (sick sinus syndrome) • atrial septal aneurysm Myxoma and other tumours* * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd: Mitral Valve Rheumatic endocarditis (stenosis* or regurgitation) infective endocarditis* Mitral annulus calcification Mitral valve prolapse * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd: Mitral Valve Non-bacterial thrombotic (marantic) endocarditis. Libman-Sacks endocarditis Prosthetic heart valve* * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd: Left Ventricle Mural thrombus: • acute myocardial infarction (within previous few weeks)* • left ventricular aneurysm or akinetic segment • dilated cardiomyopathy* * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd: Left Ventricle Mural thrombus: • mechanical ‘artificial’ heart* • blunt chest injury (myocardial contusion) Myxoma and other tumours* * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd: Aortic Valve Rheumatic endocarditis (stenosis or regurgitation). Infective endocarditis* Syphilis Non-infective thrombotic (marantic) endocarditis * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd: Aortic Valve Libman-Sacks endocarditis Prosthetic heart valve* Calcific stenosis/sclerosis/calcification * substantial risk of embolism BIKHA Cardiac Sources of Embolism (in anatomical sequence) Contd. Congenital heart disease (particularly with right to left shunt) Cardiac manipulation/ surgery/ catheterisation/ valvuloplasty/ angioplasty BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) ‘Complex’ disease (fibrinoid necrosis) in small, penetrating vessels: • most common cause in middle and old age hypertensives • haemorrhages often deep in putamen (40%), caudate nucleus (85%), thalamus (15%), cerebral hemispheres (lobar) (20%), cerebellum (8%), and brainstem (8%) BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) Amyloid (congophilic) angiopathy* • most common cause in old age • haemorrhages often in lobes of cerebral hemispheres • may be associated with dementia * causes of multiple haemorrhages in the brain parenchyma BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) Vascular malformations (arteriovenous and cavernous angiomas) • dural or brain • most common cause of ICH in young normotensive people • seizures and headaches commonly antedate haemorrhage • cavernous angiomas tend to be multiple and familial BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) Caroticocavernous fistula Hereditary haemorrhagic telangiectasia Saccular aneurysms • cause 1 in 13 intracerebral haemorrhages (2 in 13 <65 years old), usually in conjunction with subarachnoid haemorrhage BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) Atheromatous aneurysm Septic arteritis and mycotic aneurysms Necrotising angitis of the CNS* Arterial dissection * causes of multiple haemorrhages in the brain parenchyma BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) Intracerebral tumours • primary (glioblastoma, oligodendroglioma, medulloblastoma, haemangioblastoma) • metastases (melanoma, bronchial carcinoma, renal carcinoma, choriocarcinoma, endometrial carcinoma) Intracranial venous thrombosis* * causes of multiple haemorrhages in the brain parenchyma BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) A. Arterial Disease (anatomical factors) Moyamoya syndrome Occult head injury* Trauma Haemorrhagic brain infarction BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) B. Raised Blood Pressure (haemodynamic factors) Acute arterial hypertension Alcohol (also antiplatelet action, and coexistent liver disease) Amphetamines (may also cause a vasculitis) Cocaine and other sympathomimetic drugs BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) B. Raised Blood Pressure (haemodynamic factors) Monoamine oxidase A inhibitors Exposure to extreme cold Trigeminal nerve stimulation Post carotic endarterectomy, heart transplantation, or correction of congenital heart lesions BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) B. Raised Blood Pressure (haemodynamic factors) Chronic arterial hypertension, causing complex small vessel disease (see above) BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) C. Bleeding Diathesis (haemostatic factors)* Anticoagulants • risk of intracerebral haemorrhage is about 1% per year • Increased risk if elderly, previous stroke, hypertensive, small vessel disease, and if INR > 4.0 * causes of multiple haemorrhages in the brain parenchyma BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) C. Bleeding Diathesis (haemostatic factors)* Antiplatelet drugs: probably a relatively minor contributory factor Thrombolytic treatment • 0.75% of patients with myocardial infarction (>2% risk if elderly >65 years, low body weight <70-kg, hypertensive, and given alteplase as opposed to streptokinase; 0.3% risk if none of these risk factors) * causes of multiple haemorrhages in the brain parenchyma BIKHA Causes of Intracerebral Haemorrhage (10-15% of all strokes) C. Bleeding Diathesis (haemostatic factors)* Thrombocytopenia Haemophilia & other hereditary coagulation factor deficiencies (e.g. factor V) Leukaemia Diffuse intravascular coagulation * causes of multiple haemorrhages in the brain parenchyma BIKHA Risk Factors for Cerebral Infarction R e la tiv e R is k E s tim a te d a g e s ta n d a rd is e d p re v a le n c e o f e x p o s u re in p o p u la tio n (% ) 2 -4 2 -4 2 6 1 -3 3 -1 5 7 30 25 3 1 20 4 2 1 -4 3 D e fin ite in c re a s in g a g e m a le g e n d e r in c re a s in g B P c ig a re tte s m o k in g d ia b e te s m e llitu s a tria l fib rilla tio n is c h a e m ic h e a rt d is e a s e (IH D ) c a ro tid b ru it/s te n o s is tra n s ie n t is c h a e m ic a tta c k o r p re v io u s s tro k e p e rip h e ra l v a s c u la r d is e a s e (in te rm itte n t c la u d ic a tio n ) in c re a s in g p la s m a fib rin o g en BIKHA Risk Factors for Cerebral Infarction Possible hyperlipidaemia* (definite for IHD) hyperhomocystinaemia activation of the renin-angiotensinaldosterone system high plasma factor VII coagulant activity low blood fibrinolytic activity raised haematocrit * probable weak (or under-researched) positive association with ischaemic stroke, and possible weak inverse/negative association with haemorrhagic stroke BIKHA Risk Factors for Cerebral Infarction Possible raised von-Willebrand factor antigen raised tissue plasminogen activity antigen plasma viscosity (largely determined by plasma fibrinogen) physical inactivity obesity snoring and sleep apnoea * probable weak (or under-researched) positive association with ischaemic stroke, and possible weak inverse/negative association with haemorrhagic stroke BIKHA Risk Factors for Cerebral Infarction Possible recent infection family history of stroke diet (salt, fat) alcohol (none, or heavy drinking) race social deprivation stress * probable weak (or under-researched) positive association with ischaemic stroke, and possible weak inverse/negative association with haemorrhagic stroke BIKHA Infarction BIKHA Infarction BIKHA Haemorrhage BIKHA Focal Neurological and Ocular Symptoms Motor Symptoms weakness or clumsiness of one side of the body, in whole or in part (hemiparesis) simultaneous bilateral weakness (paraparesis, quadriparesis)* difficulty swallowing (dysphagia)* imbalance (ataxia)* * as an isolated symptom, this does not necessarily indicate focal brain ischaemia or haemorrhage because there are many other potential causes BIKHA Focal Neurological and Ocular Symptoms Speech/Language Disturbances difficulty understanding or expressing spoken language (dysphasia) difficulty reading (dyslexia) or writing (dysgraphia) difficulty calculating (dyscalculia) slurred speech (dysarthria)* * as an isolated symptom, this does not necessarily indicate focal brain ischaemia or haemorrhage because there are many other potential causes BIKHA Focal Neurological and Ocular Symptoms Sensory Symptoms Somatosensory • altered feeling on one side of the body, in whole or in part (hemisensory disturbance) * as an isolated symptom, this does not necessarily indicate focal brain ischaemia or haemorrhage because there are many other potential causes BIKHA Focal Neurological and Ocular Symptoms Sensory Symptoms Visual • loss of vision in one eye, in whole or in part (monocular blindness) • loss of vision in the left or the right half or quarter of the visual field (hemianopia, quadrantanopia) • bilateral blindness • double vision (diplopia)* * as an isolated symptom, this does not necessarily indicate focal brain ischaemia or haemorrhage because there are many other potential causes BIKHA Focal Neurological and Ocular Symptoms Vestibular Symptoms a spinning sensation (vertigo)* Behavioural/Cognitive Symptoms difficulty dressing, combing hair, cleaning teeth etc.; geographical disorientation; difficulty copying diagrams such as a clock, flower, or intersecting cubes (visual-spatial-perceptual dysfunction) forgetfulness (amnesia)* * as an isolated symptom, this does not necessarily indicate focal brain ischaemia or haemorrhage because there are many other potential causes BIKHA Non-focal Neurological Symptoms Generalised weakness and/or sensory disturbance ‘Blackouts’ with altered or loss of consciousness or fainting, with or without impaired vision in both eyes Incontinence of urine or faeces Confusion BIKHA Non-focal Neurological Symptoms Any of the following symptoms, if isolated:* A spinning sensation (vertigo) Ringing in ears (tinnitus) Difficulty swallowing (dysphagia) Slurred speech (dysarthria) Double vision (diplopia) Loss of balance (ataxia) * If these symptoms occur in combination, or with focal neurological symptoms, they may indicate focal cerebral ischaemia BIKHA DIFFERENTIAL DIAGNOSIS OF ISCHEMIC STROKE & TIA Clinical diagnosis of ischemic or hemorrhagic stroke depends upon clinicians understanding of brain function and pathology. Deficit that evolve over weeks are usually caused by: • Brain mass either primary or metastatic brain tumor. • Brain abscess. • Sub-dural hematoma. BIKHA DIFFERENTIAL DIAGNOSIS OF ISCHEMIC STROKE & TIA TIA may be confused with classic or complicated: • Migraine. • Seizures. BIKHA DIFFERENTIAL DIAGNOSIS OF ISCHEMIC STROKE & TIA Hemorrhagic stroke often enters in differential diagnosis: • Ischemic strokes. • Verterobasillary ischemia. • Non-specific dizziness. • Meinier’s disease. • Peripheral vestibulopathy. BIKHA Differential Diagnosis of Stroke (in order of frequency of occurrence in general practice) Metabolic/toxic encephalopathy (hypoglycaemia, non-ketotic hyperglycaemia, hyponatraemia, Wernicke-Korsakoff syndrome, hepatic encephalopathy, alcohol and drug intoxication) Functional/non-neurological (e.g. hysteria) Epileptic seizure (postictal Todd’s paresis) or non-convulsive seizures BIKHA Elements of Patient Management within a Specialist Stroke Unit Standardised (protocol driven) investigation and management Risk assessment for swallowing Active treatment of contributory factors Early rehabilitation Multidisciplinary team Rationalise medication Research opportunities Discharge planning BIKHA Tips on Triples in Acute Stroke: Some Points Worth Remembering 3 h window for safe and effective thrombolysis Avoid thrombolyis if infarction already affects more than 1/3 of MCA territory Control blood sugar tightly for 3 days Start blood pressure treatment after 3 days Take decision on tube feeding at 3 days BIKHA Tips on Triples in Acute Stroke: Some Points Worth Remembering Three complications to avoid: aspiration, venous thrombosis, infection Three groups of patients (atherothrombotic, cardioembolic and haemorrhagic) get three different treatment: aspirin, warfarin or neither Delay warfarin for 3 weeks after significant embolic infarct BIKHA The 7 D’s of Stroke Care Detection: Dispatch Delivery Door Data Decision Drugs BIKHA Algorithm for Suspected Stroke: Goals for Management of Stroke Identify signs of possible stroke Critical EMS assessments and actions : Support ABCs; give oxygen if needed Perform prehospital stroke assessment Establish time when patient last known normal (Note: therapies may be available beyond 3 hours from onset) Transport; consider triage to a center with a stroke unit if appropriate; consider bringing a witness, family member or caregiver Alert hospital Check glucose if possible ContinuedBIKHA Immediate general assessment and stabilization: Assess ABCs, vital signs Provide oxygen if hypoxemic Obtain IV access and blood samples Check glucose; treat if indicated Perform neurologic screening assessment Activate stroke team Order emergent CT scan of brain Obtain 12-lead ECG Immediate neurologic assessment by stroke team or designee Review patient history Establish symptom onset Perform neurologic examination (NIH Stroke Scale or Canadian Neurologic scale) ContinuedBIKHA Does CT scan show any hemorrhage? No Hemorrhage Hemorrhage Probable acute ischemic stroke; consider Consult neurologist or neurosurgeon; fibrinolytic therapy: consider transfer if not available Check for fibrinolytic exclusions Repeat neurologic exam: are deficits rapidly improving to normal Not a Candidate Administer aspirin Patient remains candidate for fibrinolytic therapy Candidate Begin stroke pathway Review risks / benefits with patient and family: If Admit to stroke unit if available acceptable Monitor BP; treat if indicated Give tPA Monitor neurologic status; emergent CT if deterioration No anticoagulants or antiplatelet treatment for 24 hours Monitor blood glucose; treat if needed Initiate supportive therapy; treat comorbidities BIKHA Critical Time Periods Immediate general assessment 10 minutes Immediate neurologic assessment 25 minutes Acquisition of head CT 25 minutes Interpretation of the CT Scan 45 minutes Administration of fibrinolytics, timed from ED arrival 60 minutes Administration of fibrinolytics, timed from onset of symptoms 3 hours Admission to a monitored bed 3 hours BIKHA BIKHA